Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N′-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent

被引:11
作者
Moussa, Iman A. [1 ]
Banister, Samuel D. [1 ]
Giboureau, Nicolas [2 ,3 ]
Meikle, Steven R. [2 ,3 ]
Kassiou, Michael [1 ,2 ,3 ]
机构
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
关键词
Piperazines; Sigma receptors; Positron emission tomography; Fluorine-18; PRECLINICAL ACUTE TOXICITY; BINDING-SITE; LIGANDS; COCAINE; PHARMACOLOGY; RADIOTRACER; INVOLVEMENT; ANTAGONISTS; CHAPERONES; AFFINITY;
D O I
10.1016/j.bmcl.2011.09.028
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N-(2-Benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine (6, sigma(1) K-i = 2.6 nM) was radiolabeled with fluorine-18 to provide a potential sigma(1) receptor radioligand for use in positron emission tomography (PET). Radiofluorination of the appropriate tosylate precursor furnished [F-18]6 with a specific activity of 45 GBq/mu mol, in an average radiochemical yield of 18% and greater than 98% radiochemical purity. MicroPET imaging in Papio hamadryas baboon brain revealed [F-18]6 uptake consistent with sigma receptor distribution, and specificity for sigma receptors was demonstrated in a haloperidol pre-treated animal. [F-18]6 possesses suitable properties for PET imaging of sigma(1) receptors, and further investigation of this sigma(1) receptor tracer is warranted. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6820 / 6823
页数:4
相关论文
共 46 条
[1]   The sigma receptor as a ligand-regulated auxiliary potassium channel subunit [J].
Aydar, E ;
Palmer, CP ;
Klyachko, VA ;
Jackson, MB .
NEURON, 2002, 34 (03) :399-410
[2]   Fluorine-18 Chemistry for PET: A Concise Introduction [J].
Banister, Samuel ;
Roeda, Dirk ;
Dolle, Frederic ;
Kassiou, Michael .
CURRENT RADIOPHARMACEUTICALS, 2010, 3 (02) :68-80
[3]   Characterization of the cocaine binding site on the sigma-1 receptor [J].
Chen, Yuenmu ;
Hajipour, Abdol R. ;
Sievert, Michael K. ;
Arbabian, Marty ;
Ruoho, Arnold E. .
BIOCHEMISTRY, 2007, 46 (11) :3532-3542
[4]   Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands [J].
Cobos, E. J. ;
Entrena, J. M. ;
Nieto, F. R. ;
Cendan, C. M. ;
Del Pozo, E. .
CURRENT NEUROPHARMACOLOGY, 2008, 6 (04) :344-366
[5]  
Collier TL, 2007, CURR PHARM DESIGN, V13, P51
[6]  
Collier TL, 1996, J LABELLED COMPD RAD, V38, P785
[7]   Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain [J].
Elsinga, PH ;
Tsukada, H ;
Harada, N ;
Kakiuchi, T ;
Kawamura, K ;
Vaalburg, W ;
Kimura, Y ;
Kobayashi, T ;
Ishiwata, K .
SYNAPSE, 2004, 52 (01) :29-37
[8]   Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine [J].
Fischer, Steffen ;
Wiese, Christian ;
Maestrup, Eva Grosse ;
Hiller, Achim ;
Deuther-Conrad, Winnie ;
Scheunemann, Matthias ;
Schepmann, Dirk ;
Steinbach, Joerg ;
Wuensch, Bernhard ;
Brust, Peter .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) :540-551
[9]  
Halldin C, 2001, Q J NUCL MED, V45, P139
[10]   Sigma receptor ligands: Possible application as therapeutic drugs and as radiopharmaceuticals [J].
Hashimoto, Kenji ;
Ishiwata, Kiichi .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (30) :3857-3876